But I do think theres a place for orals in the market, both clinically and just efficacy-wise. The challenge, Verbeke explains, is in targeting the right patient population, particularly those for whom moderate weight loss and convenience may outweigh the maximal clinical effect
Kapoor will start you on a low dose of Ozempic
If you need to prioritize, the three most critical baseline tests are HbA1c, a Comprehensive Metabolic Panel, and TSH
On their own, GLP-1s often cause side effects like nausea and diarrhea
A patient with Type 2 diabetes choosing between a GLP-1 and an older oral agent is no longer making a purely glycemic decision
Gallbladder disease, including gallstones (cholelithiasis), is a recognised risk with GLP-1 receptor agonists and can present with pain radiating to the back or right shoulder